Nerac

Information That Drives Innovation

We’re here to help with your research needs
+1 860 872 7000
Customer Access
  • Home
  • What We Do
    • Innovation Insights and Consulting Practice
    • Regulatory
    • Medical Device and Life Sciences
    • Technology Scouting and Innovation
    • Market Research
    • Intellectual Property
    • Commercialization Services for TTOs and Start-Ups
    • Critical Updates
  • Who We Serve
  • How to Engage
  • Why Nerac?
  • Meet our Team
    • Leadership Team
    • Our Analysts
    • Our Partners
  • Nerac Insights and Publications
    • Articles
    • Case Studies
    • Press Room
    • Videos
    • Webcasts
    • White Papers
  • Contact Us
You are here: Home / Nerac Insights / Articles / Technology Transfer Problems and Perspectives: An Examination of Recent Literature

Technology Transfer Problems and Perspectives: An Examination of Recent Literature

Facebook0
Google+0
LinkedIn0
Twitter0

By Nerac IP Analysts

The major idea behind the Bayh-Dole act passed in 1980 was to move control of technology discovered under federal grant funding from the federal government itself to universities.  The goal was to speed development of new technology from university labs to the marketplace.  How that was to be done was not specified in the legislation nor was any new enabling funding provided.  The initial idea seems straight-forward enough, but of course, implementation has been sporadic and variably effective.  By some estimates, the value of developed technology has been equivalent to approximately one or two percent of the initial research expense.  This, of course, raises questions about how effective technology transfer has been and how effective we should expect it to be.   This report is motivated by the desire to understand what is happening in technology transfer (TT) especially in the US.  What are the limitations and challenges in TT?  Have they changed in recent years, especially after the shock in economic conditions beginning in 2007-2008?
Download the complete article here.

The article is free!

Simply fill in the form below, verify your email address
and you’ll be sent a link to download the article.
Please wait...
Loader

Related Posts

  • Early Stage University Technology Transfer and Commercialization Analysis
    80
    By John Leavitt, Ph.D. Nerac Analyst, Originally Published: July 23, 2014 Universities are hotbeds for innovation and entrepreneurship – take, for example, Stanford University, MIT, and Harvard. In the case of Stanford all you have to do is to look up Page Mill Road in Palo Alto, California, and the surrounding Silicone Valley to see the…
    Tags: universities, nerac, major, technology, transfer
  • Six Tips for Effective Technology Scouting
    43
    By Kevin Closson, Nerac Analyst, Originally published June, 2013 One of the most pressing issues for companies big and small, in every industry, is the need to stay relevant in their markets. Innovation is rightly seen as the chief way to achieve this goal. It is also widely acknowledged that innovation cannot be the only province…
    Tags: technology, nerac, effective
  • Nutraceutical IP and Regulatory Claims
    41
    Originally published September, 2008 Food makers increasingly rely on patented technologies to improve functionality, but strict regulations hamper marketing benefits. The United States functional foods market is relatively immature compared to that of nutraceuticals. From an intellectual property standpoint, this may be because functional food technology develops from within the food industry, while nutraceuticals may…
    Tags: technology, ip
  • Case Studies
  • White Papers
  • Webcasts
  • Articles
    • Nerac Strategist
    • Energy
    • Food & Nutrition
    • Intellectual Property
    • Regulatory
    • Technology & Innovation
    • Medical Device & Healthcare
    • Pharmaceutical
    • Engineering
    • Market Research
    • Critical Alerts
    • Chemistry/Advanced Materials
  • Press Room

Click here to learn more about….

3d printing advanced materials aerospace Ask Kevin Videos biotech CFDA clinical literature evaluations commercialization strategies competitive intelligence conflict minerals Disruptive Technologies emerging markets energy EU MDR FDA food Industry 4.0 innovation Inspiring Next intellectual property intellectual property strategies IP market analysis market research medical device medical devices nerac Nerac client questions Nerac Strategist notified body audit open innovation Order 650 patenting strategies patent landscape pharmaceutical Post-Market Surveillance R&D regulatory regulatory compliance Robert Beinstein Rosemarie Szostak specialty chemicals Sustainable Development Goals technology scouting XcellR8
  • Facebook
  • Google+
  • Linkedin
  • RSS
  • Twitter
  • YouTube
  • Career Opportunities

Copyright © 2021 Nerac · One Technology Drive · Tolland, CT 06084 · 1.860.872.7000

Sign Up for the Nerac Strategist

Like what you see? Sign up here to receive the Nerac Strategist newsletter, a compilation of analyst insights on rapidly developing industry issues, compliance challenges and commercial opportunities!
  • This field is for validation purposes and should be left unchanged.